Literature DB >> 29348500

Myeloid-derived suppressor cells coming of age.

Filippo Veglia1, Michela Perego1, Dmitry Gabrilovich2.   

Abstract

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of cells generated during a large array of pathologic conditions ranging from cancer to obesity. These cells represent a pathologic state of activation of monocytes and relatively immature neutrophils. MDSCs are characterized by a distinct set of genomic and biochemical features, and can, on the basis of recent findings, be distinguished by specific surface molecules. The salient feature of these cells is their ability to inhibit T cell function and thus contribute to the pathogenesis of various diseases. In this Review, we discuss the origin and nature of these cells; their distinctive features; and their biological roles in cancer, infectious diseases, autoimmunity, obesity and pregnancy.

Entities:  

Mesh:

Year:  2018        PMID: 29348500      PMCID: PMC5854158          DOI: 10.1038/s41590-017-0022-x

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  172 in total

1.  The origin and function of tumor-associated macrophages.

Authors:  Yang Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2014-09-15       Impact factor: 11.530

2.  Increased monocytic CD14⁺HLADRlow/- myeloid-derived suppressor cells in obesity.

Authors:  Yi Bao; Juanfen Mo; Lingjuan Ruan; Guo Li
Journal:  Mol Med Rep       Date:  2014-11-11       Impact factor: 2.952

3.  Myeloid-derived suppressor cells prevent type 1 diabetes in murine models.

Authors:  Bingjiao Yin; Ge Ma; Chun-Yu Yen; Zuping Zhou; George X Wang; Celia M Divino; Sofia Casares; Shu-Hsia Chen; Wen-Chin Yang; Ping-Ying Pan
Journal:  J Immunol       Date:  2010-10-18       Impact factor: 5.422

4.  S100-alarmin-induced innate immune programming protects newborn infants from sepsis.

Authors:  Thomas Ulas; Sabine Pirr; Beate Fehlhaber; Marie S Bickes; Torsten G Loof; Thomas Vogl; Lara Mellinger; Anna S Heinemann; Johanna Burgmann; Jennifer Schöning; Sabine Schreek; Sandra Pfeifer; Friederike Reuner; Lena Völlger; Martin Stanulla; Maren von Köckritz-Blickwede; Shirin Glander; Katarzyna Barczyk-Kahlert; Constantin S von Kaisenberg; Judith Friesenhagen; Lena Fischer-Riepe; Stefanie Zenker; Joachim L Schultze; Johannes Roth; Dorothee Viemann
Journal:  Nat Immunol       Date:  2017-05-01       Impact factor: 25.606

5.  Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Authors:  C Marcela Diaz-Montero; Mohamed Labib Salem; Michael I Nishimura; Elizabeth Garrett-Mayer; David J Cole; Alberto J Montero
Journal:  Cancer Immunol Immunother       Date:  2008-04-30       Impact factor: 6.968

6.  Polyunsaturated fatty acids promote the expansion of myeloid-derived suppressor cells by activating the JAK/STAT3 pathway.

Authors:  Dehong Yan; Quan Yang; Maohua Shi; Limei Zhong; Changyou Wu; Tao Meng; Huiyong Yin; Jie Zhou
Journal:  Eur J Immunol       Date:  2013-08-29       Impact factor: 5.532

7.  CD33(+) /HLA-DR(neg) and CD33(+) /HLA-DR(+/-) Cells: Rare Populations in the Human Decidua with Characteristics of MDSC.

Authors:  Catharina Bartmann; Markus Junker; Sabine E Segerer; Sebastian F Häusler; Mathias Krockenberger; Ulrike Kämmerer
Journal:  Am J Reprod Immunol       Date:  2016-02-03       Impact factor: 3.886

Review 8.  Chronic inflammation and cytokines in the tumor microenvironment.

Authors:  Glauben Landskron; Marjorie De la Fuente; Peti Thuwajit; Chanitra Thuwajit; Marcela A Hermoso
Journal:  J Immunol Res       Date:  2014-05-13       Impact factor: 4.818

9.  Differential Regulation of Myeloid-Derived Suppressor Cells by Candida Species.

Authors:  Anurag Singh; Felipe Lelis; Stefanie Braig; Iris Schäfer; Dominik Hartl; Nikolaus Rieber
Journal:  Front Microbiol       Date:  2016-10-13       Impact factor: 5.640

Review 10.  The role of myeloid-derived suppressor cells in immune ontogeny.

Authors:  Soren Gantt; Ana Gervassi; Heather Jaspan; Helen Horton
Journal:  Front Immunol       Date:  2014-08-13       Impact factor: 7.561

View more
  514 in total

Review 1.  Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3+ regulatory T cells.

Authors:  Mark D Mannie; Kayla B DeOca; Alexander G Bastian; Cody D Moorman
Journal:  Cell Immunol       Date:  2020-07-15       Impact factor: 4.868

2.  Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III Trial.

Authors:  A Ari Hakimi; Martin H Voss; Fengshen Kuo; Alejandro Sanchez; Ming Liu; Briana G Nixon; Lynda Vuong; Irina Ostrovnaya; Ying-Bei Chen; Victor Reuter; Nadeem Riaz; Yuan Cheng; Parul Patel; Mahtab Marker; Albert Reising; Ming O Li; Timothy A Chan; Robert J Motzer
Journal:  Cancer Discov       Date:  2019-01-08       Impact factor: 39.397

3.  Polymorphonuclear myeloid-derived suppressor cells attenuate allergic airway inflammation by negatively regulating group 2 innate lymphoid cells.

Authors:  Yingjiao Cao; Yumei He; Xiangyang Wang; Yongdong Liu; Kun Shi; Zheng Zheng; Xue Su; Aihua Lei; Juan He; Jie Zhou
Journal:  Immunology       Date:  2019-01-17       Impact factor: 7.397

4.  Murine myeloid-derived suppressor cells are a source of elevated levels of interleukin-27 in early life and compromise control of bacterial infection.

Authors:  Madeline Gleave Parson; Juanita Grimmett; Jordan K Vance; Michelle R Witt; Brittany G Seman; Travis W Rawson; Logan Lyda; Christopher Labuda; Joo-Yong Jung; Shelby D Bradford; Cory M Robinson
Journal:  Immunol Cell Biol       Date:  2019-02-08       Impact factor: 5.126

Review 5.  Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy.

Authors:  Victoria Wu; Huwate Yeerna; Nijiro Nohata; Joshua Chiou; Olivier Harismendy; Francesco Raimondi; Asuka Inoue; Robert B Russell; Pablo Tamayo; J Silvio Gutkind
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

Review 6.  Recent advances on the crosstalk between neutrophils and B or T lymphocytes.

Authors:  Sara Costa; Dalila Bevilacqua; Marco A Cassatella; Patrizia Scapini
Journal:  Immunology       Date:  2018-10-10       Impact factor: 7.397

7.  Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma.

Authors:  Emilien Loeuillard; Jingchun Yang; EeeLN Buckarma; Juan Wang; Yuanhang Liu; Caitlin Conboy; Kevin D Pavelko; Ying Li; Daniel O'Brien; Chen Wang; Rondell P Graham; Rory L Smoot; Haidong Dong; Sumera Ilyas
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

8.  The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling.

Authors:  Eslam Mohamed; Rosa A Sierra; Jimena Trillo-Tinoco; Yu Cao; Patrick Innamarato; Kyle K Payne; Alvaro de Mingo Pulido; Jessica Mandula; Shuzhong Zhang; Paul Thevenot; Subir Biswas; Sarah K Abdalla; Tara Lee Costich; Kay Hänggi; Carmen M Anadon; Elsa R Flores; Eric B Haura; Shikhar Mehrotra; Shari Pilon-Thomas; Brian Ruffell; David H Munn; Juan R Cubillos-Ruiz; Jose R Conejo-Garcia; Paulo C Rodriguez
Journal:  Immunity       Date:  2020-04-14       Impact factor: 31.745

Review 9.  The complexity of neutrophils in health and disease: Focus on cancer.

Authors:  Silvia Carnevale; Somayehsadat Ghasemi; Anna Rigatelli; Sebastien Jaillon
Journal:  Semin Immunol       Date:  2020-09-18       Impact factor: 11.130

10.  Harmful Effects of Granulocytic Myeloid-Derived Suppressor Cells on Tuberculosis Caused by Hypervirulent Mycobacteria.

Authors:  Caio César Barbosa Bomfim; Eduardo Pinheiro Amaral; Igor Santiago-Carvalho; Gislane Almeida Santos; Érika Machado Salles; Araceli Aparecida Hastreiter; Rogério Silva do Nascimento; Fabrício M Almeida; Thatiana Lopes Biá Ventura Simão; Andreza Linhares Rezende; Mario Hiroyuki Hirata; Ricardo Ambrósio Fock; José Maria Álvarez; Elena B Lasunskaia; Maria Regina D'Império Lima
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.